Sleep disorders : Difficulty falling asleep : Melatonin 5 mg 3 to 4 hours before an imposed sleep period over 4 weeks. Difficulty maintaining sleep : A high dose, repeated low doses, or a controlled-release formulation. Children 6 months to 14 years of age with sleep disorders : Melatonin 2 to 5 mg has been used.
Measles can cause serious health complications, such as pneumonia or encephalitis, and even death. Children younger than 5 years of age and adults older than 20 years of age are at high risk of getting a serious case of measles.easles was eliminated from the U.S. in 2000 (elimination is defined as the interruption of continuous measles transmission lasting more than 12 months). Since elimination was declared in 2000, the annual number of people reported to have measles ranged from a low of 37 people in 2004 to a high of 668 people in 2014.
On October 18, 2007, FDA approved expanding the age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years. The vaccine was first approved by FDA in January 2005 for people ages 11 to 55 years. Until now, Menomune was the only meningococcal vaccine available in the United States for use in children ages 2 and older. Menactra and Menomune are manufactured by sanofi pasteur Inc. of Swiftwater, Pa.